Norway
# |
Name |
Gross Profit |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 43.87 M
|
Dec. 31, 2023 | USD 4.95 | -0.09% |
|
Norway |
|
2 |
USD 19.54 M
|
Dec. 31, 2023 | USD 2.17 | -0.37% |
|
Norway |
|
3 |
USD 12.90 M
|
Dec. 31, 2023 | USD 0.23 | 0.44% |
|
Norway |
|
4 |
USD 11.10 M
|
Dec. 31, 2023 | USD 1.20 | -0.29% |
|
Norway |
|
5 |
USD 6.82 M
|
Dec. 31, 2023 | USD 3.46 | 4.14% |
|
Norway |
|
6 |
USD 4.34 M
|
Dec. 31, 2023 | USD 0.17 | -2.50% |
|
Norway |
|
7 |
USD 1.13 M
|
Dec. 31, 2023 | USD 1.36 | 33.77% |
|
Norway |
|
8 |
USD 293.54 K
|
Dec. 31, 2023 | USD 0.11 | -3.45% |
|
Norway |
|
9 |
USD 34.75 K
|
Dec. 31, 2023 | USD 0.77 | -0.80% |
|
Norway |
|
10 |
USD 0.00
|
Dec. 31, 2023 | USD 0.22 | 4.62% |
|
Norway |
|
11 |
USD -271.75 K
|
Dec. 31, 2023 | USD 0.19 | 2.37% |
|
Norway |
The Pharmaceuticals company in Norway with the highest Gross Profit is Photocure ASA (Oslo Stock Exchange: PHO.OL) at USD 43.87 M.
The Pharmaceuticals company in Norway with the lowest Gross Profit is Ultimovacs ASA (Oslo Stock Exchange: ULTI.OL) at USD -271.75 K.
The top 10 Pharmaceuticals companies in Norway by Gross Profit are Photocure ASA, Navamedic ASA, Nykode Therapeutics AS, ArcticZymes Technologies ASA, Gentian Diagnostics ASA, Hofseth BioCare ASA, Lifecare AS, PCI Biotech Holding ASA, BerGenBio ASA and Thor Medical ASA.
The bottom 10 Pharmaceuticals companies in Norway by Gross Profit are Ultimovacs ASA, Thor Medical ASA, BerGenBio ASA, PCI Biotech Holding ASA, Lifecare AS, Hofseth BioCare ASA, Gentian Diagnostics ASA, ArcticZymes Technologies ASA, Nykode Therapeutics AS and Navamedic ASA.